▎药明康德

WuXi AppTec Listed in TIME Magazine's World's Best Companies in Sustainable Growth 2025

Shanghai, January 3, 2024 - WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life sciences industries, announced its inclusion in TIME magazine’s “World’s Best Companies in Sustainable Growth 2025” ranking. This recognition underscores WuXi AppTec’s solid business performance and unwavering commitment to sustainable development. 

The “World’s Best Companies in Sustainable Growth 2025” ranking, developed by TIME, a globally renowned publisher, in partnership with Statista, a global data and business intelligence platform, is a comprehensive analysis focused on three key dimensions – Revenue Growth, Financial Stability, and Environmental Impact. The ranking aims to identify companies that excel in sustainable development while maintaining strong financial health.

WuXi AppTec's inclusion in the ranking is a testament to the company’s holistic approach to growth and sustainability. Through its unique integrated CRDMO business model, WuXi AppTec continues to meet customers’ evolving needs, follow scientific innovations, generate industry insights, capture new molecule opportunities, and drive long-term business growth.

As a responsible corporate citizen, WuXi AppTec has deepened its commitment to sustainability by integrating ESG priorities into every aspect of global operations. In 2024, WuXi AppTec ranked #1 in the Global Life Sciences Tools & Services Industry in S&P Global's Corporate Sustainability Assessment, and received a gold medal in the EcoVadis business sustainability rating. In the same year, WuXi AppTec was included in the 2024 Dow Jones Sustainability Indices (DJSI) and maintained its AA MSCI ESG rating for the fourth consecutive year. In both 2023 and 2024, WuXi AppTec was listed in the S&P Global Sustainability Yearbook and in the FTSE4Good Index Series, and was named as an Industry and Regional “Top-Rated” company by Sustainalytics. In addition, WuXi AppTec joined the United Nations Global Compact (UNGC) in 2024 to support the initiative’s ten sustainability principles and in 2023, WuXi AppTec joined the Science Based Targets initiative (SBTi) to reduce carbon emissions.

Looking ahead, WuXi AppTec remains steadfast in its mission to advance discoveries and meaningful progress for patients, moving toward a future where “every drug can be made and every disease can be treated”.

About WuXi AppTec

As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development, and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, advanced therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received an AA ESG rating from MSCI for the fourth consecutive year in 2024, and its open-access platform is enabling more than 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated."